Clinicopathological characteristics of the analysed cohort
| UTUC cohort | ||||
| Málaga | Marburg | Erlangen | All | |
| n (%) | ||||
| Total number of cases | 48 | 75 | 126 | 249 |
| Localisation UTUC | ||||
| Renal pelvis | 27 (58.6) | 38 (50.6) | 4 (3,2) | 69 (27.9) |
| Ureter | 19 (41.3) | 31 (41.3) | 0 | 50 (20.2) |
| Renal pelvis and ureter | 0 | 6 (8.0) | 122 (96.8) | 128 (51.8) |
| Not available | 2 | 0 | 0 | 2 |
| pT stage | ||||
| pTa | 4 (8.9) | 17 (23.2) | 19 (15.1) | 40 (16.5) |
| pT1 | 17 (37.8) | 11 (15.1) | 23 (18.2) | 51 (20.9) |
| pT2 | 10 (22.2) | 12 (16.4) | 16 (12.6) | 38 (15.6) |
| pT3 | 12 (26.7) | 29 (39.7) | 51 (40.5) | 92 (37.7) |
| pT4 | 2 (4.4) | 4 (5.5) | 17 (13.5) | 23 (9.4) |
| Not available | 3 | 2 | 0 | 5 |
| pN stage | ||||
| pN0 | 30 (75.0) | 20 (27.4) | 0 | 50 (44.2) |
| pN+ | 9 (22.5) | 10 (13.7) | 0 | 19 (16.8) |
| pNX | 1 (2.5) | 43 (58.9) | 0 | 44 (38.9) |
| Not available | 8 | 2 | 126 | 136 |
| WHO grading 1973 | ||||
| G1 | 7 (15.2) | 0 | 0 | 7 (5.9) |
| G2 | 20 (43.5) | 36 (48.0) | 0 | 56 (46.3) |
| G3 | 19 (41.3) | 39 (52.0) | 0 | 58 (47.9) |
| Not available | 2 | 0 | 126 | 128 |
| WHO grading 2016 | ||||
| Low-grade | 12 (60.0) | 22 (29.3) | 0 | 34 (35.8) |
| High-grade | 8 (40.0) | 53 (70.7) | 0 | 61 (64.2) |
| Not available | 28 | 0 | 126 | 154 |
| Gender | ||||
| Female | 12 (26.1) | 27 (36.0) | 40 (31.7) | 79 (32.0) |
| Male | 34 (73.9) | 48 (64.0) | 86 (68.3) | 168 (68.0) |
| Not available | 2 | 0 | 0 | 2 |
| Age (years) | ||||
| Median | 67 | 71 | 71 | 70 |
| Minimum | 40 | 40 | 41 | 40 |
| Maximum | 87 | 89 | 94 | 94 |
| Not available | 2 | 2 | 0 | |
pN, pathological nodal status; pT, pathological tumour stage; UTUC, upper tract urothelial carcinoma; WHO, World Health Organization.